Kathryn M. McNeil
2014
In 2014, Kathryn M. McNeil earned a total compensation of $246.1K as Former Vice President of Investor Relations at Cellectar Biosciences, a 51% increase compared to previous year.
Compensation breakdown
| Salary | $225,000 |
|---|---|
| Other | $21,129 |
| Total | $246,129 |
McNeil received $225K in salary, accounting for 91% of the total pay in 2014.
McNeil also received $21.1K in other compensation.
Rankings
In 2014, Kathryn M. McNeil's compensation ranked 12,115th out of 13,032 executives tracked by ExecPay. In other words, McNeil earned more than 7.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,115 out of 13,032 | 7th |
Division Manufacturing | 4,622 out of 4,966 | 7th |
Major group Chemicals And Allied Products | 1,576 out of 1,686 | 7th |
Industry group Drugs | 1,278 out of 1,365 | 6th |
Industry Pharmaceutical Preparations | 979 out of 1,043 | 6th |
Source: SEC filing on June 1, 2016.
McNeil's colleagues
We found four more compensation records of executives who worked with Kathryn M. McNeil at Cellectar Biosciences in 2014.